Retrospective analysis of patients (pts) with metastatic melanoma (MM) showing long-term response (LTR) to vemurafenib (Vb).

被引：0
|
作者：
Galli, Giulia
Di Guardo, Lorenza
Cimminiello, Carolina
Cavalieri, Stefano
Rodolfo, Monica
Rivoltini, Licia
Valeri, Barbara
Bono, Aldo
Tolomio, Elena
Del Vecchio, Michele
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e21001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21001
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Long-Term Response to Vemurafenib Therapy in Patients with metastatic malignant Melanoma
    Groffik, A.
    Mueller-Brenne, T.
    Rudolph, B.
    Rietz, S.
    Grabbe, S.
    Loquai, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 908 - 908
  • [2] Survivorship experience for patients (pts) with metastatic melanoma (MM) on long-term targeted therapy (TT).
    Khoo, Chloe Chia Hoey
    Lai-Kwon, Julia Elizabeth
    Lo, Serigne
    Milne, Donna
    Mohamed, Mustafa Abdi
    Raleigh, Jeanette
    Smith, Kortnye Maureen
    Jefford, Michael
    Sandhu, Shahneen Kaur
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] LONG-TERM RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH VISCERAL METASTATIC MELANOMA
    COATES, AS
    SEGELOV, E
    ANNALS OF ONCOLOGY, 1994, 5 (03) : 249 - 251
  • [4] Evaluation of the Long-Term Survival after Treatment with Ipilimumab or Vemurafenib in Patients with Metastatic Malignant Melanoma
    Rudolph, B. M.
    Groffik, A.
    Faidt, D.
    Grabbe, S.
    Loquai, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 2 - 3
  • [5] Real-world (RW) study of metastatic colorectal cancer (mCRC) patients (pts) with long-term response (LTR) to regorafenib (REG) in the USA: An updated analysis
    Kim, R. D.
    Pan, X.
    Zhang, Y.
    Lunacsek, O.
    Pisa, F.
    Ostojic, H.
    Peeters, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S41 - S41
  • [6] Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo
    Takeshi Fukumoto
    Susumu Fujiwara
    Masanobu Sakaguchi
    Masahiro Oka
    Naomi Kiyota
    Yasuo Ejima
    Koichi Nakajima
    Chikako Nishigori
    European Journal of Dermatology, 2017, 27 : 177 - 178
  • [7] Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo
    Fukumoto, Takeshi
    Fujiwara, Susumu
    Sakaguchi, Masanobu
    Oka, Masahiro
    Kiyota, Naomi
    Ejima, Yasuo
    Nakajima, Koichi
    Nishigori, Chikako
    EUROPEAN JOURNAL OF DERMATOLOGY, 2017, 27 (02) : 177 - 178
  • [8] Association of plasma exosomal mRNA changes with long-term durable response to ipilimumab (IPI) in metastatic melanoma (MM) patients
    Coticchia, Christine M.
    Sullivan, Ryan J.
    Hurley, James D.
    Hu, Lan
    Lawrence, Donald P.
    Flaherty, Keith
    Blackmon, Shauna M.
    Brock, Graham
    O'Neill, Vincent J.
    Skog, Johan
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Long-term efficacy of intrathecal interleukin-2 (IT IL2) in metastatic melanoma (MM) patients (pts) with leptomeningeal disease (LMD)
    Glitza, I. C.
    Rohlfs, M. L.
    Bassett, R., Jr.
    John, I.
    Richard, J.
    Iqbal, M.
    Bernzen, T.
    Gerber, D. L.
    Lacey, C.
    Diab, A.
    Amaria, R. N.
    Woodman, S. E.
    Patel, S. P.
    Yee, C.
    Hwu, W. J.
    Hwu, P.
    Papadopoulos, N.
    Davies, M. A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S109 - S109
  • [10] Long-term survival of patients with metastatic melanoma (MM) treated with dacarbazine (DTIC) or temozolomide (TMZ)
    Kim, C.
    Lee, C. W.
    Klasa, R.
    Shah, A.
    Savage, K. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345